Eterna Therapeutics Inc (ERNA) — Capital Reinvestment Ratio
Latest as of March 2019:
0.05x
Eterna Therapeutics Inc (ERNA) has a Capital Reinvestment Ratio of 0.05x as of March 2019, meaning it reinvests 0% of its operating cash flow ($780.00K) in capital expenditures ($41.00K). See ERNA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$780.00K
USD
Capital Expenditures
$41.00K
USD
Data as of
Mar 2019
Most recent filing
Eterna Therapeutics Inc Capital Reinvestment Ratio (2009–2019)
This chart tracks Eterna Therapeutics Inc's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Eterna Therapeutics Inc (2009–2019)
Year-by-year Capital Reinvestment Ratio for Eterna Therapeutics Inc from 2009 to 2019. For live market cap and broader valuation context, see Eterna Therapeutics Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.40x | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $2.50 Million | $1.91 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow